$3.80 per Treatment
At the same time, semaglutide reduces the amount of glucagon, a hormone that increases blood sugar levels
44% of people on semaglutide experience nausea, for example, according to a 2022 analysis
glutathione is not typically a cause of elevated liver enzymes
#Pharma #Healthcare #DiabetesCare #ObesityManagement #Innovation #IndiaPharma #GLP1 #Zydus #TorrentPharma (Source:-pharmabiz) To view or add a comment, sign in Big shift incoming in India's obesity & diabetes care: Novo Nordisk's key #patent on #semaglutide (the active ingredient in #Ozempic & #Wegovy) expires on March 20, 2026
The combined effect of appetite suppression, increased energy, and fewer cravings creates a more favorable environment for weight loss or weight stability, especially compared to other antidepressants that may promote weight gain